Javascript must be enabled to continue!
Integrated control strategies for dengue, Zika, and Chikungunya virus infections
View through CrossRef
Arboviruses are a major threat to public health in tropical regions, encompassing over 534 distinct species, with 134 capable of causing diseases in humans. These viruses are transmitted through arthropod vectors that cause symptoms such as fever, headache, joint pains, and rash, in addition to more serious cases that can lead to death. Among the arboviruses, dengue virus stands out as the most prevalent, annually affecting approximately 16.2 million individuals solely in the Americas. Furthermore, the re-emergence of the Zika virus and the recurrent outbreaks of chikungunya in Africa, Asia, Europe, and the Americas, with one million cases reported annually, underscore the urgency of addressing this public health challenge. In this manuscript we discuss the epidemiology, viral structure, pathogenicity and integrated control strategies to combat arboviruses, and the most used tools, such as vaccines, monoclonal antibodies, treatment, etc., in addition to presenting future perspectives for the control of arboviruses. Currently, specific medications for treating arbovirus infections are lacking, and symptom management remains the primary approach. However, promising advancements have been made in certain treatments, such as Chloroquine, Niclosamide, and Isatin derivatives, which have demonstrated notable antiviral properties against these arboviruses in vitro and in vivo experiments. Additionally, various strategies within vector control approaches have shown significant promise in reducing arbovirus transmission rates. These encompass public education initiatives, targeted insecticide applications, and innovative approaches like manipulating mosquito bacterial symbionts, such as Wolbachia. In conclusion, combatting the global threat of arbovirus diseases needs a comprehensive approach integrating antiviral research, vaccination, and vector control. The continued efforts of research communities, alongside collaborative partnerships with public health authorities, are imperative to effectively address and mitigate the impact of these arboviral infections on public health worldwide.
Title: Integrated control strategies for dengue, Zika, and Chikungunya virus infections
Description:
Arboviruses are a major threat to public health in tropical regions, encompassing over 534 distinct species, with 134 capable of causing diseases in humans.
These viruses are transmitted through arthropod vectors that cause symptoms such as fever, headache, joint pains, and rash, in addition to more serious cases that can lead to death.
Among the arboviruses, dengue virus stands out as the most prevalent, annually affecting approximately 16.
2 million individuals solely in the Americas.
Furthermore, the re-emergence of the Zika virus and the recurrent outbreaks of chikungunya in Africa, Asia, Europe, and the Americas, with one million cases reported annually, underscore the urgency of addressing this public health challenge.
In this manuscript we discuss the epidemiology, viral structure, pathogenicity and integrated control strategies to combat arboviruses, and the most used tools, such as vaccines, monoclonal antibodies, treatment, etc.
, in addition to presenting future perspectives for the control of arboviruses.
Currently, specific medications for treating arbovirus infections are lacking, and symptom management remains the primary approach.
However, promising advancements have been made in certain treatments, such as Chloroquine, Niclosamide, and Isatin derivatives, which have demonstrated notable antiviral properties against these arboviruses in vitro and in vivo experiments.
Additionally, various strategies within vector control approaches have shown significant promise in reducing arbovirus transmission rates.
These encompass public education initiatives, targeted insecticide applications, and innovative approaches like manipulating mosquito bacterial symbionts, such as Wolbachia.
In conclusion, combatting the global threat of arbovirus diseases needs a comprehensive approach integrating antiviral research, vaccination, and vector control.
The continued efforts of research communities, alongside collaborative partnerships with public health authorities, are imperative to effectively address and mitigate the impact of these arboviral infections on public health worldwide.
Related Results
CLINICAL COURSE AND OUTCOME OF PATIENTS WITH DENGUE FEVER, DENGUE HEMORRHAGIC FEVER AND DENGUE SHOCK SYNDROME IN A TERTIARY CARE HOSPITAL IN RECENT ENDEMIC 2022
CLINICAL COURSE AND OUTCOME OF PATIENTS WITH DENGUE FEVER, DENGUE HEMORRHAGIC FEVER AND DENGUE SHOCK SYNDROME IN A TERTIARY CARE HOSPITAL IN RECENT ENDEMIC 2022
Background: Dengue fever cases have been increased almost 30-fold over last 50 years and now reaches an estimated 100 million clinically apparent infections annually. This rapid in...
Evaluation of Serological Diagnostic Assays for Distinguishing Zika From Dengue Virus Infections in Thailand
Evaluation of Serological Diagnostic Assays for Distinguishing Zika From Dengue Virus Infections in Thailand
Abstract
Zika virus (ZIKV) is a mosquito-borne flavivirus that has recently emerged as a global health threat. The emergence of ZIKV has increased the incidence of neonates...
A35 The first laboratory confirmation of chikungunya outbreak in Ethiopia
A35 The first laboratory confirmation of chikungunya outbreak in Ethiopia
Abstract
Chikungunya is a viral disease (genus Alphavirus) which is transmitted to humans by infected mosquitoes—including Aedes aegypti and A. albopictus. An outbre...
Development of a Recurrent Neural Network Model for Prediction of Dengue Importation
Development of a Recurrent Neural Network Model for Prediction of Dengue Importation
ObjectiveWe aim to develop a prediction model for the number of imported cases of infectious disease by using the recurrent neural network (RNN) with the Elman algorithm1, a type o...
EPIDEMIOLOGY OF DENGUE AND CHIKUNGUNYA INFECTION IN BANGALORE, KARNATAKA - 2024
EPIDEMIOLOGY OF DENGUE AND CHIKUNGUNYA INFECTION IN BANGALORE, KARNATAKA - 2024
Background: Dengue and Chikungunya viral infection is emerging as a serious public health problem in Karnataka. An enhanced testing facility can generate information on the epidemi...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Molecular identification and phylogenetic analysis of chikungunya virus among dengue-negative patients in Kolkata, India
Molecular identification and phylogenetic analysis of chikungunya virus among dengue-negative patients in Kolkata, India
Dengue and chikungunya are co-circulating vector-borne diseases that share a significant number of clinical symptoms. To identify variables to aid physicians in making rapid and ef...
Spatial and epidemiologic features of dengue in Sabah, Malaysia
Spatial and epidemiologic features of dengue in Sabah, Malaysia
Abstract
In South East Asia, dengue epidemics have increased in size and geographical distribution in recent years. Most studies investigating de...

